| æ®ä¸–界å«ç”Ÿç»„织(WHO)统计,2010å¹´,å† çŠ¶åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–æ€§å¿ƒè„ç—…(å† å¿ƒç—…)所致æ»äº¡å 总æ»äº¡äººå£çš„10%,ä½å±…第一[1]。在我国,有大约800-1000ä¸‡çš„å† å¿ƒç—…æ‚£è€…,而且éšç€äººä»¬ç”Ÿæ´»ä¹ 惯的改å˜,å† å¿ƒç—…çš„å‘ç—…è¶Šæ¥è¶Šå¹´è½»åŒ–,一些é’ä¸å¹´äººå› 心肌梗æ»è¿›å…¥æ€¥è¯Šå®¤ç”šè‡³æ»äº¡ã€‚éšç€ç»çš®å† 状动脉çƒå›Šæˆå½¢æœ¯(PTCA)åŠç»çš®å† 状动脉支架æ¤å…¥æœ¯(PCI)广泛应用于心绞痛或心肌梗æ»çš„æ²»ç–—å¹¶å–得了显著疗效,但术åŽåŠå¹´æœ‰30%~40%的病人出现å†ç‹çª„(RS)[2,3]。应è¿è€Œç”Ÿçš„è¯ç‰©æ¶‚层支架虽使RS率有所下é™ã€‚然而支架内RSä»ç„¶æ˜¯ä¸€ä¸ªæ£˜æ‰‹çš„问题[6]。RS病人普é出现症状å¤å‘并需è¦è¿›è¡Œå†æ¬¡å¹²é¢„治疗,å…¶ç»æµŽè€—费是相当高的,ä¹Ÿæ˜¾è‘—å½±å“æ‚£è€…术åŽçš„远期疗效。PTCA或PCIæ—¶,çƒå›ŠæŸä¼¤åŠ¨è„‰å†…çš®åŠä¸å±‚,引起血管平滑肌细胞(VSMC)表型转化,è¿ç§»,增殖åŠç»†èƒžå¤–åŸºè´¨åˆæˆ,å½¢æˆæ–°ç”Ÿå†…膜。新生内膜的形æˆå’Œå¢žæ®–是引起支架内å†ç‹çª„çš„å…³é”®å› ç´ [7]。血管平滑肌细胞过度增殖内皮细胞æŸä¼¤,脱è½,基底膜,è‡´è¡€å°æ¿èšé›†,与æŸä¼¤çš„å†…çš®ç»†èƒžåˆ†æ³Œå†…çš®ç´ (ET),5羟色胺(5HT),è¡€ç®¡ç´§å¼ ç´ (Ang)ç‰å› å,引起血管收缩,åŒæ—¶ä¿ƒå‡è¡€ç‰©è´¨å¦‚è¡€æ “ç´ A2(TXA2),è¡€å°æ¿æºæ€§ç”Ÿé•¿å› å(PDGF),二磷酸腺苷(ADP)ç‰é‡Šæ”¾å¢žåŠ ,ä½¿è¡€å°æ¿é»é™„å’Œèšé›†,å½¢æˆè¡€æ “[8,9]。血管é‡å¡‘å½¢ç ”ç©¶è¡¨æ˜Žè¡€ç®¡æˆå½¢æœ¯åŽæ—©æœŸçš„VSMC增生往往å‘生在术åŽ2周内,ä½†å†…è†œå¢žåŽšå´æŒç»åˆ°12周,å› æ¤è¡€ç®¡é‡å¡‘在å†ç‹çª„çš„å‘生过程ä¸èµ·é‡è¦ä½œç”¨ã€‚åŸºå› æ²»ç–—å†ç‹çª„是目å‰å›½å†…外较关注的çƒç‚¹,其主è¦ç–略是对é¶ç»†èƒžâ€”内皮细胞进行修饰,ä½¿å…¶è¡¨è¾¾ç‰¹å®šåŸºå› ,呿Œ¥æŠ‘制å†ç‹çª„的作用。主è¦çš„分åé¶ç‚¹æ˜¯ç»†èƒžåŸºå› ,ç»†èƒžå‘¨æœŸè°ƒèŠ‚åŸºå› ,æŠ—è¡€æ “å½¢æˆåŸºå› ,å¢žåŠ ä¸€æ°§åŒ–æ°®åˆæˆçš„åŸºå› ,æŠ‘åˆ¶å¹³æ»‘è‚Œç»†èƒžå¢žæ®–çš„ç»†èƒžæ ¸å› å,è¡€å°æ¿è¡åŒ–ç”Ÿé•¿å› å,抑制血管平滑肌增生的åä¹‰æ ¸é…¸åŸºå› ã€‚è¡€ç®¡ç´§å¼ ç´ â…¡(angiotensinâ…¡,Angâ…¡)å—ä½“ä¸»è¦æœ‰ä¸¤åž‹,å³Angâ…¡1åž‹å—体å³AT1Rå’ŒAngâ…¡2åž‹å—体å³AT2R。Angâ…¡å¯é€šè¿‡AT1å—ä½“çš„æ¿€æ´»å‘æŒ¥ç¼©è¡€ç®¡,促细胞增生è¿ç§»,促进新生内膜形æˆ,细胞外基质沉积,促å‘炎症,è¡€æ “å½¢æˆåŠæ°§åŒ–应激的效应。AT2å—ä½“æ¿€æ´»åˆ™å‘æŒ¥èˆ’å¼ è¡€ç®¡,æŠ—å¢žç”ŸæŠ—è¡€æ “,诱导凋亡åŠäº§ç”Ÿä¸€æ°§åŒ–æ°®NOçš„æ•ˆåº”ã€‚å› æ¤å¯¹RAS进行干预,从å—体水平阻æ–AT1 angioplasty.In vivo is the method which can directly transfer the Purpose gene into the target cells.In vivo is the most directly gene therapy.The most uesd of gene carrier is virus carrier (such as adenovirus carrier, retroviruses carrier) and the non-virus carrier (such as plasmid carrier, liposomes) carrier, however,they have many fault. The physical phenomenon of electroporation has been successfully exploited in vitro for the delivery of genes. Electriceld effects on living cells have been under investigation since the1960-1970,This first research primarily dealt with describing the phenomena of reversible and irreversible membrane breakdown in vitro.This physical phenomenon was termed electroporation. Numerous studies have demonstrated that electroporation can successf deliver the plasmidDNA into target cells.Therfore,we make the clamp shape vsscular electrode sheet which can apply with the vsscular electroporation,to study the effects of Electroporation on the AT2R gene transfected into rat carotid arteries and study the effects of AT2R gene transfer on neointimal hyperplasia in rat carotid arteries after balloon angioplasty. Methods1.Utilizing plasmid pUHD-10.3/AT2R as a template, the full length cDNA fragment of AT2R gene was amplified by polymerase chain reaction (PCR). Eukaryotic expression vector pEGFP-N2/AT2R was constructed by cloning AT2R gene into vector pEGFP-N2.2.Make the clamp shape vsscular electrode sheet which can apply with the vsscular electroporation.3.Electroporation-mediated AT2R gene transfected into rat carotid arteries after the establishment of rat carotid balloon injury restenosis model.4. The expression of AT2R in arteries were evaluated by immunohistochemistry.5. The expression of AT2R in arteries were evaluated by RT-PCR.6. The influence on neointimal of AT2R expression were evaluated by HE stainingResults1. Eukaryotic expressing vector pEGFP-N2/AT2R has been successfully constructed and confirmed identical to the sequence in database of gene bank by sequencing test.2. The clamp shape vsscular electrode can be used for in vivo Electroporation .3. The balloon catheter injury can establish an arterial restenotic model. 4. Electroporation-mediated AT2R gene delivered into injured rat carotid arteries significantly up - regulated the levels of AT2R in neointima from day7 to day 14. compared with no Electroporation-mediated group,no transfection group and GFP transfection group,the Electroporation-mediated gene transfer group, the levels of AT2RmRNA in Electroporation-mediated gene transfer group is significantl increase.5. The result of RT-PCR is that electroporation-mediated AT2R gene delivered into injured rat carotid arteries significantly up - regulated the levels of AT2R mRNA in neointima from day7 to day 14. At day 21, compared with no Electroporation-mediated group,no transfection group and GFP transfection group., the levels of AT2RmRNA in Electroporation-mediated gene transfer group is significantl increase.6. AT2R transfection significantly reduced Neointima/media area ratio (I/M) significantly(0.76±0.08),(1.39±0.08),(1.32±0.10),P<0.01).Conclusions1. The results of this study provide evidence that in vivo electroporation is an effective means for introducing naked AT2R DNA into the blood vessel wall ;2. Gene transfer of AT2R in vessel wall may effectively inhibit VSMC proliferation and neointimal hyperplasia in the rat carotid arteries after balloon angioplasty. |